Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: AstraZeneca UK Ltd
Woman and Man Max 99 years
AstraZeneca UK Ltd
Update Il y a 4 ans
A study to assess the effectiveness of esomeprazole 40 mg once daily in subjects with continuing gastroesophageal reflux disease (GORD) symptoms following treatment with a previous full dose proton pump inhibitor (PPI). An 8 week, open label, multicentre study
The primary objective of this study is to assess the change in the frequency of heartburn from baseline value at entry to the end of the study, after 8-weeks treatment with Esomeprazole 40mg compared ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
AstraZeneca UK Ltd
Update Il y a 4 ans
A phase IV, 6-week, randomised, double-blind, multicentre, parallel group, comparative study to evaluate the efficacy of rosuvastatin 5 mg and atorvastatin 10 mg in UK Asian subjects with primary hypercholesterolaemia
The primary objective of this UK study is to compare the efficacy of rosuvastatin 5 mg with atorvastatin 10 mg in reducing LDL-C in Asian subjects with hypercholesterolaemia after 6 weeks of treatment...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
AstraZeneca UK Ltd
Update Il y a 4 ans
Quetiapine Augmentation In Treatment-Resistant Depression – An Open Pilot Study
To determine the efficacy of quetiapine in the treatment of depression at 8 weeks, assessed by calculation of the proportion of subjects responding by week 8, derived from the change in Montgomery Asb...
Country
None
organs
None
Specialty
None
unknown
More information